Newron Pharmaceuticals S.p.A. Secures Up to €38 Million to Accelerate Phase III Evenamide Program in Treatment-Resistant Schizophrenia

Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond pivotal 12-week results, supporting development of evenamide as the p...

February 18, 2026 | Wednesday | News
Christopher Cargill Positions Nxera Pharma Co., Ltd. for Scalable Growth and Profitability Following Strategic Pipeline and Commercial Expansion in 2025

  Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its co...

February 17, 2026 | Tuesday | Company results
InnoCare Pharma Doses First Patient in Phase II/III Trial of Soficitinib for Chronic Spontaneous Urticaria

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced &nb...

February 17, 2026 | Tuesday | News
Norman Schwartz Charts Performance Reset for Bio-Rad Laboratories, Inc. After Turbulent 2025

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced financial results for the fourth quarte...

February 16, 2026 | Monday | Company results
Sanofi Appoints Belén Garijo as CEO, Signaling Bold Leadership Shift to Strengthen Innovation and Performance

Belén Garijo to become Chief Executive Officer of Sanofi Sanofi's Board of Directors met on February 11, 2026, and decided not to renew the Direc...

February 13, 2026 | Friday | News
CEO Daniel O’Day Underscores Strength of Gilead’s HIV Franchise After Solid 2025 Results

  Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025 Biktarvy Sales Increased 7% Year-Over-Year to $1...

February 12, 2026 | Thursday | Company results
FUJIFILM Biotechnologies Opens £400M UK Biomanufacturing Expansion in Teesside

FUJIFILM Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing innovativ...

February 12, 2026 | Thursday | News
Novartis Expands US Innovation Footprint with USD 23 Billion R&D Push, Including New San Diego Research Hub

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including C...

February 09, 2026 | Monday | News
Slingshot Biosciences Strengthens UK and EU Presence with Synthetic Cell Mimic Technology

Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene thera...

February 06, 2026 | Friday | News
From Injections to Pills: How Mass Spectrometry Is Reshaping Biopharma

  Drug delivery is entering a period of rapid reinvention, driven as much by analytical innovation as by molecular design. In this BioPharma BoardRoo...

February 04, 2026 | Wednesday | Interaction
mRNA’s Next Act: Why Analytical Science Matters More Than Ever

As mRNA technologies move rapidly beyond COVID-19 into vaccines and therapies for cancer, rare diseases, and personalized medicine, scientific complexity i...

February 04, 2026 | Wednesday | Interaction
Automation, SPE, and Mass Spectrometry: The New Front Line of PFAS Regulation

As regulators worldwide intensify scrutiny of per- and polyfluoroalkyl substances (PFAS), laboratories are being pushed into a new era of sensitivity, sp...

February 04, 2026 | Wednesday | Interaction
AGC Biologics Earns Anvisa GMP Certification to Support Global Commercialization of Customer Biologics

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional d...

February 05, 2026 | Thursday | News
Formerra Expands Distribution of Evonik CARE Brand Medical Grades Across U.S. and Canada

Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada  Formerra, a leader in performance materials distribution, to...

February 05, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close